Sheikh Vikarunnessa

Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial

Kausik K. Ray, Roel P T Troquay, Frank L.J. Visseren et al. · The Lancet Diabetes & Endocrinology · 2023 · 282 citations · Full text

Plexins Are GTPase-Activating Proteins for Rap and Are Activated by Induced Dimerization

Yuxiao Wang, Huawei He, Nishi Srivastava et al. · Science Signaling · 2012 · 165 citations

Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial

R. Scott Wright, Frederick J. Raal, Wolfgang Köenig et al. · Cardiovascular Research · 2024 · 65 citations · Full text

LDL Phenotype in Subjects with Mild Cognitive Impairment and Alzheimer's Disease

Sheikh Vikarunnessa, Myron Weiner, Gloria Lena Vega · Journal of Alzheimer s Disease · 2013 · 10 citations · Full text